Verdict94/ 100
Grade A · #1CoreAge Rx
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Visit CoreAge RxHead-to-head verdict
CoreAge Rx vs Enhance MD
Two GLP-1 providers, compared side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.
Published by The GLP-1 Verdict
Pricing sources checked: CoreAge Rx: August 2026 · Enhance MD: October 2026
vs
Verdict85/ 100
Grade B · #12Enhance MD
Earns its keep on pricing transparency — every tier is published, dose-flat and includes combo and microdose options — but the verdict holds it back for a compounded-only formulary and service in 40 states plus DC, not all 50.
Visit Enhance MDThe verdict
Winner: CoreAge Rx
CoreAge Rx takes it with a higher Verdict Score — 94/100 to 85/100 (grade A vs B). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. Enhance MD still earns its place — shoppers who value knowing the exact price of every dose and combo up front, and who want lab testing folded into the program.
The score compares published program terms and features; it does not measure clinical outcomes or predict which treatment will suit you.
Factor by factor
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
92Real-world results84
92
Real-world results84
97Price honesty88
97
Price honesty88
96Prescriber access82
96
Prescriber access82
88Formulary choice86
88
Formulary choice86
95Cancellation fairness84
95
Cancellation fairness84
93Member support86
93
Member support86
Price, coverage & features
| Metric | CoreAge Rx | Enhance MD |
|---|---|---|
| Verdict Score | 94/100 | 85/100 |
| Grade | A | B |
| Semaglutide | $99/mo | $212/mo |
| Tirzepatide | $149/mo | $280/mo |
| Coverage | All 50 states | 40 states + DC |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | No | No |
CoreAge Rx
What we like
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation
The caveats
- Not the cheapest — flat-price challengers like Trimi Health and Alan Meds undercut its sticker price
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Enhance MD
What we like
- Fully transparent tiered pricing: compounded semaglutide $212/mo, tirzepatide $280/mo, microdose $169/mo and a sema/tirz combo at $322/mo
- Dose-flat pricing — the sticker doesn't climb as you titrate up
- Metabolic lab testing every 6 months plus real provider support built into the plan
- NAD+ available for patients pursuing metabolic and longevity goals alongside the GLP-1
The caveats
- Every GLP-1 here is compounded, not FDA-approved — no brand-name fallback
- No oral or sublingual route
- Serves 40 states plus DC — not Alabama, Arkansas, Georgia, Hawaii, Louisiana, Mississippi, Missouri, North Dakota, South Carolina or Tennessee
- Higher entry price than the flat-rate discounters in this ranking (first month runs $112, then $212)
Our pick — visit
Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.
Visit CoreAge Rx Read the full CoreAge Rx review →Also worth a look
Shoppers who value knowing the exact price of every dose and combo up front, and who want lab testing folded into the program.
Visit Enhance MD Read the full Enhance MD review →Keep comparing
Neither of these has to be the answer: the rivals we rank against CoreAge Rx cover the 7 programs closest to it, and the same shortlist for Enhance MD does the reverse.
More on CoreAge Rx
More on Enhance MD
Or browse the full comparison hub, every head-to-head A to Z and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.